Arrestins play an essential role in regulating signaling and trafficking of G protein-coupled receptors (GPCRs). Visual arrestins (arrestin-1 and 4) specifically interact with opsins while non-visual arrestins (arrestin-2 and 3) interact with multiple GPCRs and also bind phosphoinositides, components of the endocytic machinery (e.g., clathrin and 22-adaptin), and various signaling molecules (e.g., Src family members and MAP kinases). Crystallographic analysis reveals that arrestins have a similar basal structure containing N- and C-domains joined by a polar core. Disruption of the polar core is thought to occur upon receptor binding and result in an """"""""active"""""""" conformation that regulates arrestin interaction with GPCRs and additional proteins. Although the structural basis for arrestin activation as well as for arrestin interaction with GPCRs and signaling molecules remains largely unknown, we recently co-crystallized arrestin-2 with phosphoinositides and with clathrin, key components of the endocytic machinery. In this application, we propose to extend our structural analysis of arrestin-2 and further define its role in binding receptors and mediating endocytosis. The specific objectives are to: 1. Perform crystallographic analysis of arrestin complexes with 22-adaptin and a phosphorylated receptor peptide. Although structure/function analysis has provided important insight into the domains that mediate arrestin interaction with receptors and 22-adaptin, mechanistic insight into the integration of these binding events is lacking. We propose to crystallize and solve structures of arrestin-2 in complex with a phosphorylated receptor peptide and 22-adaptin. High-resolution crystallographic analysis of these complexes should provide insight into: 1) the binding interfaces of arrestin-2 with receptor and 22-adaptin; 2) the mechanism of arrestin-2 activation; and 3) the mechanism of assembly of a multi-protein endocytic complex. 2. Characterize the biology of arrestin interaction with GPCRs and endocytic proteins. The dynamics of arrestin interaction with clathrin-coated pits is complex and involves multiple protein-protein and protein-lipid interactions. We will use insight from our structural analysis to further define the mechanistic basis for arrestin-mediated regulation of GPCR endocytosis. These studies will utilize various biochemical, molecular, and cell biological strategies to probe the interaction of arrestins with endocytic components and elucidate the function of such interactions in receptor trafficking. Overall, these studies should provide insight into differences in the basal and activated forms of arrestin-2 and provide a mechanistic basis for how non-visual arrestins function as GPCR-regulated adaptor proteins. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
3R37GM047417-15S1
Application #
7382422
Study Section
Molecular Neuropharmacology and Signaling Study Section (MNPS)
Program Officer
Dunsmore, Sarah
Project Start
1994-01-01
Project End
2011-02-28
Budget Start
2008-03-05
Budget End
2009-02-28
Support Year
15
Fiscal Year
2008
Total Cost
$185,600
Indirect Cost
Name
Thomas Jefferson University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Komolov, Konstantin E; Benovic, Jeffrey L (2018) G protein-coupled receptor kinases: Past, present and future. Cell Signal 41:17-24
Luo, Jiansong; Busillo, John M; Stumm, Ralf et al. (2017) G Protein-Coupled Receptor Kinase 3 and Protein Kinase C Phosphorylate the Distal C-Terminal Tail of the Chemokine Receptor CXCR4 and Mediate Recruitment of ?-Arrestin. Mol Pharmacol 91:554-566
Carr 3rd, Richard; Koziol-White, Cynthia; Zhang, Jie et al. (2016) Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms. Mol Pharmacol 89:94-104
Carr 3rd, Richard; Schilling, Justin; Song, Jianliang et al. (2016) ?-arrestin-biased signaling through the ?2-adrenergic receptor promotes cardiomyocyte contraction. Proc Natl Acad Sci U S A 113:E4107-16
Carr 3rd, Richard; Benovic, Jeffrey L (2016) From biased signalling to polypharmacology: unlocking unique intracellular signalling using pepducins. Biochem Soc Trans 44:555-61
Tian, Xufan; Irannejad, Roshanak; Bowman, Shanna L et al. (2016) The ?-Arrestin ARRDC3 Regulates the Endosomal Residence Time and Intracellular Signaling of the ?2-Adrenergic Receptor. J Biol Chem 291:14510-25
Tian, Xufan; Kang, Dong Soo; Benovic, Jeffrey L (2014) ?-arrestins and G protein-coupled receptor trafficking. Handb Exp Pharmacol 219:173-86
Kang, Dong Soo; Tian, Xufan; Benovic, Jeffrey L (2014) Role of ?-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking. Curr Opin Cell Biol 27:63-71
Kook, S; Zhan, X; Cleghorn, W M et al. (2014) Caspase-cleaved arrestin-2 and BID cooperatively facilitate cytochrome C release and cell death. Cell Death Differ 21:172-84
Carr 3rd, Richard; Du, Yang; Quoyer, Julie et al. (2014) Development and characterization of pepducins as Gs-biased allosteric agonists. J Biol Chem 289:35668-84

Showing the most recent 10 out of 35 publications